Folate Analog Metabolic Inhibitor [EPC]

356121 reported adverse events

Drugs of this class: METHOTREXATE PRALATREXATE

These side effects are most commonly reported by patients taking drugs of the Folate Analog Metabolic Inhibitor [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 66373
1 RHEUMATOID ARTHRITIS 33239
2 ARTHRALGIA 31195
3 PAIN 30324
4 OFF LABEL USE 24633
5 FATIGUE 24350
6 NAUSEA 20166
7 JOINT SWELLING 18878
8 HEADACHE 17173
9 DRUG INTOLERANCE 16896
See all common reactions for Folate Analog Metabolic Inhibitor [EPC]

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3597 0.8999
1 SWOLLEN JOINT COUNT INCREASED 1000 0.8787
2 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 263 0.8738
3 RHEUMATOID FACTOR POSITIVE 2892 0.8101
4 RHEUMATIC FEVER 1164 0.7593
5 PEMPHIGUS 6176 0.7577
6 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1534 0.7361
7 SYNOVITIS 9258 0.6875
8 C-REACTIVE PROTEIN ABNORMAL 2754 0.6847
9 HAND DEFORMITY 5883 0.6473
See all enriched reactions for Folate Analog Metabolic Inhibitor [EPC]